Oncology Precision Medicine Market, Size, Global Forecast 2022-2027
Over the years, the burden of cancer continues to grow globally, creating substantial pressure on patients, their families, communities and healthcare systems. Hence, precision medicine has been derived as a global healthcare approach, systematically using patient data to inform personalized treatment decisions. Precision medicine, a blend of molecular biology techniques and system biology, is an emerging approach in the medication and prevention of cancer. Prominently, around the world, oncology precision medicine has emerged as potentially transformative, offering promising superior treatment outcomes for all cancer patients. According to Renub Research, Global Oncology Precision Medicine Market is expected to reach US$ 64.66 Billion by 2027.
